Problems in the diagnosis and management of unilateral retinoblastoma.
The improved prognosis for life in retinoblastoma challenges us to readdress the severe morbidity associated with late presentation and treatment, particularly in unilateral disease. Three cases of unilateral sporadic retinoblastoma are presented to illustrate the range of therapeutic options that need to be considered in management and to show that early recognition of the tumour and local treatment have the potential to minimise morbidity and to enable binocular vision to be retained.
Billson
F A
FA
University Department of Ophthalmology, Sydney Eye Hospital, Woolloomooloo, New South Wales, Australia.
Dunlop
I S
IS
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001918:Brachytherapy; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005134:Eye Neoplasms / Q000175:diagnosis* / Q000628:therapy; D005260:Female; D005654:Fundus Oculi; D006801:Humans; D007223:Infant; D011379:Prognosis; D012175:Retinoblastoma / Q000175:diagnosis* / Q000628:therapy; D014057:Tomography, X-Ray Computed; D015348:Vision, Binocular; D014792:Visual Acuity; D014821:Vitrectomy
D000970:Antineoplastic Agents